Dongbao Bio-Tech released its 2024 annual performance, with a net profit attributable to the parent company of 85.9827 million yuan, a year-on-year decrease of 28.28%
I'm PortAI, I can summarize articles.
Dongbao Bio-Tech released its 2024 annual report, with operating revenue of 885 million yuan, a year-on-year decrease of 9.19%; net profit attributable to shareholders was 85.9827 million yuan, a year-on-year decrease of 28.28%; net profit excluding non-recurring gains and losses was 79.0893 million yuan, a year-on-year decrease of 28.17%; basic earnings per share were 0.1448 yuan/share. The company plans to distribute a cash dividend of 0.25 yuan (tax included) for every 10 shares
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments